TwinPharma is specialized in the sales, marketing, and distribution of specialty pharmaceuticals in the Netherlands, Belgium, and Luxembourg. TwinPharma contributes to the improvement of pharmaceutical care in the Benelux by introducing value-added medicines that were previously not available in these countries. By forming a strategic alliance with FrostPharma of Sweden and ExCEEd Orphan (Czech Republic), the group can target more than 180 million Europeans in 25 countries. The founders, Gert van Alewijk and Bauke Buwalda, joined forces in TwinPharma in 2006. www.twinpharma.com
| Website | http://www.twinpharma.com |
| Revenue | $4 million |
| Employees | View employees |
| Technologies |
HTML
,
Twitter
,
Nginx
+4 more
(view full list)
|
| Industry | Manufacturing General, Manufacturing |
| Competitors | Johnson & Johnson, Roche, Novartis, AbbVie, Merck & Co., Inc., Pfizer, Sanofi, GSK, AstraZeneca, Bristol Myers Squibb +46 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular TwinPharma employee's phone or email?
TwinPharma Questions
The TwinPharma annual revenue was $4 million in 2026.
The NAICS codes for TwinPharma are [3254, 32541, 325, 32].
The SIC codes for TwinPharma are [28, 2834, 283].
